Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open-labeled single-blinded randomized controlled trial

被引：0
|
作者：
Chakraborty, Disha [1 ]
De, Abhishek [2 ]
Khan, Azhar [2 ]
Dhar, Sandipan [3 ]
Raychaudhuri, Siba P. [4 ,5 ,6 ]
机构：
[1] Sacramento VA Med Ctr, Dept Dermatol & Clin Immunol, Mather, CA USA
[2] Calcutta Natl Med Coll & Hosp, Dept Dermatol, Kolkata, India
[3] Inst Child Hlth Kolkata, Pediat Dermatol, Kolkata, India
[4] Univ Calif Davis, Dept Dermatol, Davis, CA USA
[5] Univ Calif Davis, Sch Med, Dept Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA USA
[6] VA Northern Calif Hlth Care Syst, Rheumatol, Sacramento, CA USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年
关键词：
crisaborole; phosphodiesterase-4; inhibitor; topical calcineurin inhibitor; tacrolimus; atopic dermatitis; eczema;
D O I：
10.1111/ijd.17572
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：402 / 404
页数：3
相关论文
共 50 条
  • [31] Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies
    Paller, AS
    Lebwohl, M
    Fleischer, AB
    Antaya, R
    Langley, RG
    Kirsner, RS
    Blum, RR
    Rico, MJ
    Jaracz, E
    Crowe, A
    Linowski, GJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) : 810 - 822
  • [32] Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis
    Boguniewicz, Mark
    Paller, Amy S.
    Tom, Wynnis L.
    Lebwohl, Mark G.
    Blumenthal, Robin L.
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Hughes, Matty H.
    Zane, Lee T.
    Hebert, Adelaide A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB397 - AB397
  • [33] An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
    Mudaliyar, Vinodhini R.
    Pathak, Asha
    Dixit, Alok
    Kumar, Sweta S.
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2020, 10 (04):
  • [34] The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
    Abidi, Afroz
    Rizvi, Dilshad Ali
    Saxena, Kshitij
    Chaudhary, Savita
    Ahmad, Ali
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (01) : 16 - 22
  • [35] Proactive Treatment of Adult Facial Seborrhoeic Dermatitis with 0.1 % Tacrolimus Ointment: Randomized, Double-blind, Vehicle-controlled, Multi-centre Trial
    Kim, Tae-Wook
    Mun, Je-Ho
    Jwa, Seung-Wook
    Song, Margaret
    Kim, Hoon-Soo
    Ko, Hyun-Chang
    Kim, Moon-Bum
    Song, Ki-Hoon
    Lee, Sook-Kyung
    Seo, Jong-Keun
    Lee, Deborha
    Kim, Byung-Soo
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (05) : 557 - 561
  • [36] Comparative evaluation of the efficacy and safety of dermabrasion followed by a prostaglandin E2 analogue (dinoprostone) versus dermabrasion followed by tacrolimus ointment 0.1% in localized stable vitiligo
    Kaur, J.
    Kumar, S.
    Brar, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 61 - 61
  • [37] Efficacy and safety of Propionibacterium extract gel versus glyceryl trinitrate ointment in the treatment of chronic anal fissure: a randomized controlled trial
    Gallo, Gaetano
    Trompetto, Mario
    Fulginiti, Serena
    La Torre, Marco
    Tierno, Simone
    Cantarella, Francesco
    Vanini, Paolo
    Tomasicchio, Giovanni
    Altomare, Donato Francesco
    Rinaldi, Marcella
    Santoro, Giulio Aniello
    Curro, Giuseppe
    Grossi, Ugo
    COLORECTAL DISEASE, 2023, 25 (08) : 1698 - 1707
  • [38] Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-blinded, active-controlled trial
    Rokni, Ghasem Rahmatpour
    Mohammadnezhad, Farzaneh
    Saeedi, Majid
    Shadi, Shiva
    Sharma, Aseem
    Sandhu, Sunmeet
    Gupta, Atula
    Goldust, Mohamad
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (11) : 3580 - 3585
  • [39] Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults (vol 75, pg 494, 2016)
    Paller, A. S.
    Tom, W. L.
    Lebwohl, M. G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) : 777 - 777
  • [40] Tacro study: efficacy and safety of a 0.1% tacrolimus nasal ointment as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT). A double-blind, randomized, placebo-controlled, multicenter trial
    Hermann, R.
    Fargeton, A.
    Grobost, V
    Riviere, S.
    Decullier, E.
    Saroul, N.
    Cartier, C.
    Philouze, P.
    Roux, A.
    Breant, V
    Colombet, B.
    Beaudoin, M.
    Faure, F.
    Dupuis-Girod, S.
    ANGIOGENESIS, 2019, 22 (04) : 594 - 594
12345